DrugDashboards

Duloxetine hydrochloride

Duloxetine hydrochloride · DULOXETINE HYDROCHLORIDE 30 mg/1 · Capsule, Delayed Release · Lilly del Caribe, Inc.

NDC 00110-3240-05 · 250000 CAPSULE, DELAYED RELEASE in 1 DRUM · DRUG FOR FURTHER PROCESSING · View full market →

Bulk ingredient — not a finished product

This NDC is a raw material (drug for further processing) sold to drug manufacturers or compounders, not a product pharmacies dispense. Retail pricing, TE codes, fragility scores, and shortage reports don't apply to bulk listings — those attach to finished products made from this ingredient.

Medicare Part D

This is a bulk ingredient, not a dispensable product — it is a raw material sold to manufacturers and compounders, so no plan prices it.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for duloxetine hydrochloride (oral solid) in the next 90 days

6 Class I/II recall(s) in 12 months · price up 12% YoY · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 2× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application
—
TE code
—
Approval date
—
Patents / exclusivity
—

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Duloxetine hydrochloride (Capsule, Delayed Release)

LabelerStrengthFirst seenLast seen
Aurobindo Pharma LimitedDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 3, 2026
Aurobindo Pharma LimitedDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 3, 2026
Lilly del Caribe, Inc.DULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 3, 2026
Aphena Pharma Solutions - Tennessee, LLCDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Aphena Pharma Solutions - Tennessee, LLCDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Eli Lilly and CompanyDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Lilly del Caribe, Inc.DULOXETINE HYDROCHLORIDE 40 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Macleods Pharmaceuticals LimitedDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Marksans Pharma LimitedDULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Sep 2, 2026
Marksans Pharma LimitedDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Marksans Pharma LimitedDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Sep 2, 2026
Proficient Rx LPDULOXETINE HYDROCHLORIDE 30 mg/1Jul 15, 2026Sep 2, 2026
Lilly del Caribe, Inc.DULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Aug 31, 2026
Aurobindo Pharma LimitedDULOXETINE HYDROCHLORIDE 60 mg/1Jul 15, 2026Aug 28, 2026
Lilly del Caribe, Inc.DULOXETINE HYDROCHLORIDE 20 mg/1Jul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Duloxetine hydrochloride — NDC 00110-3240-05," retrieved September 3, 2026, https://drugdashboards.com/drug/00110324005.

Free to cite with attribution — see how the data is put together.